Enter your email address to subscribe to this blog and receive notifications of new posts by email.
Join 59 other followers
In Pfizer on August 17, 2012 by Howard@OpenAir Tagged: bribery, Bulgaria, China, Croatia, Czech, diligence, DOJ, DPA, FCPA, Italy, Justice, Kazakhstan, marketing, Pfizer, pharma, Russia, SEC, Serbia
Tom and I talk about the Pfizer DPA, and what lessons we can learn from a company that’s been doing it right for more time than most companies have even heard of the FCPA.
[...] Week in FCPA, episode 50. The FCPAProfessor takes a clip of Peterson’s remarks on CNBC, a transcript of which is here. Tom [...]
[...] Sklar and Tom Fox have a very good discussion of the Pfizer DPA at their This Week in FCPA Blog (August [...]
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.
Create a free website or blog at WordPress.com.
The DePo Square Theme.
View more by category: TWIFCPAVideocast (48),
News Corp. (15),
UK Bribery Act (13),
Africa Sting Case (8),
State-Owned Entities (5). .
Get every new post delivered to your Inbox.